课题基金 / 基金详情

Diversity Supplement for: Engineered Asymmetric Hydrogel for Muscle Stem Cell Polarity and Fate Specification

Diversity Supplement for: Engineered Asymmetric Hydrogel for Muscle Stem Cell Polarity and Fate Specification
多样性补充:用于肌肉干细胞极性和命运规范的工程不对称水凝胶
批准号:
10807823
负责人:
Woojin Han
金额:
$4.23万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2027-01-31

项目摘要

项目成果

Woojin Han的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT Fibro-adipogenic progenitors (FAPs) are muscle-resident mesenchymal stromal cells that support muscle satellite cell (MuSC) function, including activation, proliferation, and differentiation. Unlike MuSCs, these cells reside within the muscle interstitial space and thus communicate with MuSCs through paracrine factors. In normal muscle regeneration, activated FAPs undergo apoptosis as the inflammation resolves and regeneration proceeds. However, in chronic muscle injuries and diseases, activated FAPs persist and differentiate into either myofibroblasts or adipocytes that drive fibrosis and fatty infiltration, respectively. However, to date, there is a limited understanding of how the FAPs interact with their microenvironment to regulate their activation, proliferation, and fate determination. In this Diversity Supplement application, we will determine the mechanistic role by which FAPs respond to passive and active mechanical signals via mechanosensitive PIEZO1 ion channel. This research strengthens and expands the scope of the parent R01 project by revealing how FAPs integrate biophysical signals derived from their synthetic niche and provide additional means to control MuSC polarity and cell divisions in the engineered asymmetric niche. Towards this goal, Aim 1 will determine how PIEZO1 regulates FAPs activation, proliferation, and differentiation. Aim 2 will determine how PIEZO1 in FAPs regulates extracellular matrix stiffness mechanosensing. Aim 3 will determine how PIEZO1 in FAPs regulates responsivity to tensile loading and unloading. The outcomes of this research will advance the current knowledge of FAPs biology, identify druggable targets to mitigate fibrosis and fatty infiltration in skeletal muscle injuries and diseases, and inform the design of ex vivo FAPs manufacturing platform for expanding MuSCs and/or producing FAPs secretome for acellular therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineered Asymmetric Hydrogel for Muscle Stem Cell Polarity and Fate Specification
Engineered Asymmetric Hydrogel for Muscle Stem Cell Polarity and Fate Specification
Notch-Modulatory Hydrogel for Dystrophic Muscle Stem Cell Rejuvenation and Expansion
Synthetic hydrogel for satellite cell delivery to the dystrophic diaphragm
  • 批准号:
    9901554
  • 项目类别:
  • 资助金额:
    $5.65万
  • 财政年份:
    2018
  • 负责人:
    Woojin Han
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: